Nutrition 21 litigation
This article was originally published in The Tan Sheet
Executive Summary
Purchase N.Y.-based firm files motion for partial summary judgement against InterHealth Nutraceuticals to halt six alleged instances of false advertising for ChromeMate chromium nicotinate dietary supplement. In complaint, filed in Manhattan federal court Sept. 24, Nutrition 21 asserts InterHealth ads have misled consumers about the safety of ChromeMate respective to Nutrition 21's Chromax chromium picolinate dietary supplement. Company is seeking damages including judgement that ads are false, corrective advertising and monetary damages, according to a spokesperson...
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.